Retractable Technologies (RVP) said Tuesday it was no longer pursuing a case in the US Court of International Trade against defendants involved in the issuance of a 100% tariff on syringes and needles imported from China.
The complaint was dismissed Wednesday last week, the company said.
Although the tariffs were allegedly not properly implemented, the company said it was withdrawing the complaint because it did not see itself prevailing "against the interests of a large monopolistic corporation."
The company further said that it also saw a lower risk of tariffs hurting its business after its engineers were able to enhance the transition process, significantly reducing the need to import syringes.
Price: 0.74, Change: -0.01, Percent Change: -1.50
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。